Merck Affiliates Reveal 4.9% Stake in Precigen Following Updated Filing

A recent Schedule 13G filing by Ares Trading SA and its affiliated entities, Merck Serono SA, Merck KGaA, and E. Merck KG, reveals they collectively own 4.9% of Precigen's (NASDAQ: PGEN) outstanding common stock.

The reporting persons, which have entered into a Joint Filing Agreement to report their ownership collectively, beneficially own 17,467,152 shares with sole voting and dispositive power over all these shares.

The figure is calculated using 358,035,247 shares outstanding as of July 31, 2026, as reported in Precigen's Form 10-Q. This new filing serves to update the previous disclosure, no longer exceeding the threshold for reporting as owning 5 percent or more of a class.